Kabiven

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredient in Kabiven, is a amino acid solution presented as a solution for injection for intravenous use. It provides essential amino acids for protein synthesis and nitrogen balance in patients who cannot receive enteral feeding, such as postoperative, critically ill, or malnourished individuals.

GNH USA supplies Kabiven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, clinics and other healthcare institutions worldwide.

Kabiven is an amino acid solution used in parenteral nutrition to support protein synthesis and nitrogen balance.

- Parenteral nutrition for patients unable to receive enteral feeding: supplies essential amino acids to maintain nitrogen balance. - Postoperative or critically ill patients: helps meet increased metabolic demands and supports wound healing. - Management of malnutrition when oral intake is insufficient: provides a complete amino acid profile to prevent catabolism.

Kabiven may be associated with infusion‑related adverse reactions and metabolic disturbances.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: changes in potassium, sodium, or calcium concentrations. - Phlebitis: inflammation at the infusion site. - Nausea or vomiting: gastrointestinal discomfort.

Serious or Rare Side Effects: - Metabolic acidosis: significant decrease in blood pH. - Hyperammonemia: elevated ammonia levels. - Severe allergic reaction: anaphylaxis or urticaria. - Renal impairment: worsening kidney function.

When using Kabiven, clinicians should observe several safety measures.

- Patient assessment: evaluate renal and hepatic function before initiating therapy. - Electrolyte monitoring: check serum electrolytes regularly during infusion. - Blood glucose control: monitor glucose in diabetic or hyperglycemic patients. - Compatibility check: ensure solution is compatible with other IV fluids and medications. - Infusion rate: administer according to prescribed rate to avoid metabolic complications. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven can interact with other intravenous therapies and metabolic agents.

Major Interactions (Avoid): - High‑dose glucose solutions: may exacerbate hyperglycemia when co‑administered. - Nephrotoxic drugs: concurrent use can increase risk of renal impairment.

Moderate Interactions (Monitor Closely): - Electrolyte‑containing IV fluids: may cause additive electrolyte disturbances. - Diuretics: can alter fluid and electrolyte balance during therapy. - Insulin therapy: may require dose adjustments due to changes in glucose levels.